Back to Newsroom

Motif Bio Announces Iclaprim Abstracts for ECCMID 2018 Now Online

NEW YORK, April 11, 2018 (GLOBE NEWSWIRE) — Motif Bio plc (MTFB.L) (MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, announces that iclaprim-related abstracts are now online for the upcoming 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2018) to be held in Madrid, Spain, April 21-24, 2018.